Area of research
Oncology · Molecular Biology
Research interest
Research focused on Pembrolizumab and Melanoma, with related work in Dacarbazine, Stage (stratigraphy), Mace. Notable publications include 'A Phase Ib Study of Pembrolizumab as Second-Line Therapy for Chinese Patients With Advanced or Metastatic Melanoma (KEYNOTE-151)', 'A Phase II, Randomized, Double-blind, Placebo-controlled Multicenter Trial of Endostar in Patients With Metastatic Melanoma', and 'An Evidence-Based Staging System for Mucosal Melanoma: A Proposal'.
An Evidence-Based Staging System for Mucosal Melanoma: A Proposal
A Phase Ib Study of Pembrolizumab as Second-Line Therapy for Chinese Patients With Advanced or Metastatic Melanoma (KEYNOTE-151)
A Phase II, Randomized, Double-blind, Placebo-controlled Multicenter Trial of Endostar in Patients With Metastatic Melanoma
Serum biomarkers and the prognosis of AMI patients
Cystatin C associates with the prediction of in-stent restenosis among patients receiving stent implantation
The value of exercise treadmill test in evaluation of coronary artery disease